Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community
Authors:
- Sylvia H. LeySLSylvia H. Ley
- Stewart B. HarrisSHStewart B. Harris
- Mary MamakeesickMMMary Mamakeesick
- Tina NoonTNTina Noon
- Edith FiddlerEFEdith Fiddler
- Joel GittelsohnJGJoel Gittelsohn
- Thomas M.S. WoleverTWThomas M.S. Wolever
- Philip W. ConnellyPCPhilip W. Connelly
- Robert A. HegeleRHRobert A. Hegele
- Bernard ZinmanBZBernard Zinman
- Anthony J.G. HanleyAHAnthony J.G. Hanley
- 17 March 2009
- journal article
- research article
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 180 (6) , 617-624
Abstract
Background: Risk factors for type 2 diabetes remain poorly characterized among Aboriginal Canadians. We aimed to determine the incidence of type 2 diabetes in an Aboriginal community and to evaluate prospective associations with metabolic syndrome and its components. Methods: Of 606 participants in the Sandy Lake Health and Diabetes Project from 1993 to 1995 who were free of diabetes at baseline, 540 (89.1%) participated in 10-year follow-up assessments. Baseline anthropometry, blood pressure, fasting insulin and serum lipid levels were measured. Fasting and 2-hour postload glucose levels were obtained at follow-up to determine incident cases of type 2 diabetes. Results: The 10-year cumulative incidence of diabetes was 17.5%. High adiposity, dyslipidemia, hyperglycemia, hyperinsulinemia and hypertension at baseline were associated with an increased risk of diabetes after adjustment for age and sex (all p ≤ 0.03). Metabolic syndrome had high specificity (75%–88%) and high negative predictive value (85%–87%) to correctly detect diabetes-free individuals at follow-up. It had low sensitivity (26%–48%) and low positive predictive value (29%–32%) to detect future diabetes. Metabolic syndrome at baseline was associated with incident diabetes after adjustment for age and sex, regardless of whether the syndrome was defined using the National Cholesterol Education Program criteria (odds ratio [OR] 2.03, 95% confidence interval [CI] 1.10–3.75) or the International Diabetes Federation criteria (OR 2.14, 95% CI 1.29–3.55). The association was to the same degree as that for impaired glucose tolerance assessed using the oral glucose tolerance test (OR 2.87, 95% CI 1.52–5.40; p > 0.05 for comparison of C statistics). Interpretation: Metabolic syndrome and its components can be identified with readily available clinical measures. As such, the syndrome may be useful for identifying individuals at risk of type 2 diabetes in remote Aboriginal communities.Keywords
This publication has 29 references indexed in Scilit:
- Should we dump the metabolic syndrome? NoBMJ, 2008
- Should we dump the metabolic syndrome?: YesBMJ, 2008
- Effectiveness of a Lifestyle Intervention on Metabolic Syndrome. A Randomized Controlled TrialJournal of General Internal Medicine, 2007
- The National Cholesterol Education Program–Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and DiabetesDiabetes Care, 2007
- Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes MellitusCirculation, 2005
- Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescentsThe Journal of Pediatrics, 2004
- Predicting Future Cardiovascular DiseaseDiabetes Care, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- The Prevalence of NIDDM and Associated Risk Factors in Native CanadiansDiabetes Care, 1997
- Diabetes and Impaired Glucose Tolerance in Three American Indian Populations Aged 45-74 Years: The Strong Heart StudyDiabetes Care, 1995